Showing results (1-10 of 81) with videos related to
Sort By:
Pageof 9
Clinical Medicine Insights. Case Reports|December 20, 2014
A case of fallopian tube adenofibroma: difficulties associated with differentiation from ectopic pregnancyAkimune Fukushima, Tadahiro Shoji, Shino Tanaka, et al.Oncotargets and Therapy|July 31, 2013
Analysis of the antitumor activity of gemcitabine and carboplatin against ovarian clear-cell carcinoma using the DNA damage marker γH2AXEriko Takatori, Tadahiro Shoji, Takashi Sawai, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 26, 2016
Molecular Analysis of Single Tumor Glands Using the Crypt Isolation Method in Endometrial CarcinomasTakayuki Nagasawa, Tamotsu Sugai, Tadahiro Shoji, et al.Gynecologic Oncology Case Reports|December 28, 2013
Chemoradiotherapy with irinotecan (CPT-11) for adenoid cystic carcinoma of Bartholin's gland: A case report and review of the literatureEriko Takatori, Tadahiro Shoji, Jiyu Miura, et al.Journal of Ovarian Research|June 14, 2012
Are platinum agents, paclitaxel and irinotecan effective for clear cell carcinoma of the ovary? DNA damage detected with γH2AX induced by anticancer agentsEriko Takatori, Tadahiro Shoji, Seisuke Kumagai, et al.Journal of Ovarian Research|March 23, 2020
A case of primary ovarian signet-ring cell carcinoma treated with S-1/CDDP therapyTadahiro Shoji, Ryosuke Takeshita, Tatsunori Saito, et al.The Journal of Obstetrics and Gynaecology Research|May 9, 2012
Case of peptide-YY-producing strumal carcinoid of the ovary: a case report and reviewEriko Takatori, Tadahiro Shoji, Jiyu Miura, et al.The Journal of Obstetrics and Gynaecology Research|June 27, 2013
Recurrent cervical cancer in a patient who was compound heterozygous for UGT1A1*6 and UGT1A1*28 presenting with serious adverse events during irinotecan hydrochloride/nedaplatin therapyEriko Takatori, Tadahiro Shoji, Yuki Miura, et al.The Journal of Obstetrics and Gynaecology Research|October 24, 2013
Triple simultaneous primary invasive gynecological malignancies: a case reportEriko Takatori, Tadahiro Shoji, Yuki Miura, et al.Oncotargets and Therapy|August 29, 2015
A recurrent ovarian cancer patient with a history of nine prior chemotherapy regimens who was safely treated with weekly paclitaxel plus bevacizumab and achieved a complete response: a case reportEriko Takatori, Tadahiro Shoji, Takayuki Nagasawa, et al.Pageof 9